SENSITIVE DETECTION OF BCR-ABL1 MUTATIONS - CML - CHRONIC MYELOID LEUKEMIA
"Since completion of the $3 billion, 13-year-long Human Genome Project made scientific history in 2003, the race has been on for cheaper, faster DNA sequencing methods. Even in 2003, traditional Sanger sequencing was becoming outdated, and the debut of the first next-generation sequencing (NGS) technology in 2005 set the stage for groundbreaking change in the field of genomics. Now, even as NGS methods keep evolving, more clinical labs are adopting this technology.''
Extract of Next Generation Sequencing in the Clinical Laboratory
VIDEOS
ASCO 2018 - Susan Branford about Applications for Next-Generation Sequencing
June 3, 2018, QIAGEN
Introduction to Next Generation Sequencing
September 7, 2017, George Mason Bioinformatics
Next generation sequencing-based analyses of hematological malignancies
May 1, 2017, Illumina Inc
Using next-generation sequencing to identify biomarkers in CML ********
January 10, 2017, VJHemOnc – Video Journal of Hematological Oncology
Next-Generation Sequencing and it's Applications in Biomedical Research
August 12, 2016, H2O.ai
Mutations associated with imatinib response in CML
August 3, 2016, ecancer
Mutation Analysis in Chronic Myeloid Leukemia (CML)
January 14, 2016, OncLiveTV
Next Generation Sequencing (NGS) - An Introduction
June 22, 2015, Applied Biological Materials - abm
Mutation Based Resistance to TKI Therapy - by Frank G. Haluska, MD, PhD
January 21,2013, TheOncologistJournal
ASCO 2018 - Susan Branford about Applications for Next-Generation Sequencing
June 3, 2018, QIAGEN
Introduction to Next Generation Sequencing
September 7, 2017, George Mason Bioinformatics
Next generation sequencing-based analyses of hematological malignancies
May 1, 2017, Illumina Inc
Using next-generation sequencing to identify biomarkers in CML ********
January 10, 2017, VJHemOnc – Video Journal of Hematological Oncology
Next-Generation Sequencing and it's Applications in Biomedical Research
August 12, 2016, H2O.ai
Mutations associated with imatinib response in CML
August 3, 2016, ecancer
Mutation Analysis in Chronic Myeloid Leukemia (CML)
January 14, 2016, OncLiveTV
Next Generation Sequencing (NGS) - An Introduction
June 22, 2015, Applied Biological Materials - abm
Mutation Based Resistance to TKI Therapy - by Frank G. Haluska, MD, PhD
January 21,2013, TheOncologistJournal
ARTICLES
Utilization of Next-Generation Deep Sequencing to Analyze BCR-ABL1 Kinase Domain Mutation for Imatinib-Resistant Chronic Myeloid Leukemia Patients in Vietnam
June 5, 2017, OMICS International
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
April 19, 2016, Pubmed
Detection and Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing
December 2015, ASH 2015
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.
May 14, 2015, Pubmed
Next Generation Sequencing in the Clinical Laboratory
May 1, 2015, AACC
Utilization of Next-Generation Deep Sequencing to Analyze BCR-ABL1 Kinase Domain Mutation for Imatinib-Resistant Chronic Myeloid Leukemia Patients in Vietnam
June 5, 2017, OMICS International
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
April 19, 2016, Pubmed
Detection and Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing
December 2015, ASH 2015
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.
May 14, 2015, Pubmed
Next Generation Sequencing in the Clinical Laboratory
May 1, 2015, AACC